These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38930015)

  • 1. Sodium-Glucose Cotransporter Type 2 Inhibitors Use in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry.
    Guzmán-Carreras A; Vellisca-González AM; Molina-Puente JI; García-Alonso R; Paz-Cabezas M; Sánchez-Sauce B; Aguilar-Rodríguez F; Iguarán-Bermúdez MDR; Andrès E; Lorenzo-Villalba N; Méndez-Bailón M
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930015
    [No Abstract]   [Full Text] [Related]  

  • 2. Low Muscle Strength Assessed with Dynamometry in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry.
    Guzmán-Carreras A; San Miguel-Agudo J; Paz-Cabezas M; Bernabeu-Wittel M; Muñoz-Rivas N; Sánchez-Sauce B; Aguilar-Rodríguez F; Cabeza-Osorio L; Andrès E; Lorenzo-Villalba N; Méndez-Bailón M;
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39201014
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical outcomes with the use of sodium-glucose cotransporter-2 inhibitors in patients with atrial fibrillation and type 2 diabetes mellitus: a multi-centre, real-world cohort study.
    Jang J; Park S; Kim S; Kim SH; Oh YS; Sa YK; Hwang Y; Jang SW; Ihm SH; Choi Y
    Eur J Prev Cardiol; 2024 Feb; 31(3):320-329. PubMed ID: 37798123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study.
    Park S; Jeong HE; Lee H; You SC; Shin JY
    Cardiovasc Diabetol; 2023 Jul; 22(1):191. PubMed ID: 37507739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review.
    Mentz RJ; Brunton SA; Rangaswami J
    Cardiovasc Diabetol; 2023 Nov; 22(1):316. PubMed ID: 37974185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of the PROFUND Index for 30-Day Mortality in Acute Heart Failure.
    Méndez-Bailón M; Iguarán-Bermúdez R; López-García L; Sánchez-Sauce B; Pérez-Mateos P; Barrado-Cuchillo J; Villar-Martínez M; Fernández-Castelao S; García-Klepzig JL; Fuentes-Ferrer ME; García-García A; Vilacosta I; de Miguel-Yanes JM; Casas-Rojo JM; Calvo-Manuel E; Andres E; Lorenzo-Villalba N; On Behalf Of The Heart Failure And Pluripathology Groups From The Spanish National Society Of Internal Medicine
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833368
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Characteristics and Prognostic Impact of Short Physical Performance Battery in Hospitalized Patients with Acute Heart Failure-Results of the PROFUND-IC Registry.
    López-García L; Lorenzo-Villalba N; Molina-Puente JI; Kishta A; Sanchez-Sauce B; Aguilar-Rodriguez F; Bernanbeu-Wittel M; Muñoz-Rivas N; Soler-Rangel L; Fernández-Carmena L; Andrès E; Deodati F; Trapiello-Valbuena F; Casasnovas-Rodríguez P; López-Reboiro ML; Méndez-Bailon M
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure.
    Karlström P; Pivodic A; Dahlström U; Fu M
    ESC Heart Fail; 2024 Feb; 11(1):327-337. PubMed ID: 38012065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure.
    Rahhal A; Hamamyh T; Chapra A; Zaza KJ; Najim M; Hemadneh M; Faraj H; Kanjo W; Yasin A; Toba H; Mohammed W; Hamad MK; Al-Tikrety N; Baraa Habib M; Awaisu A; Mahfouz A; Alyafei S; Arabi AR; Patel A; Al-Hijji M
    Front Cardiovasc Med; 2024; 11():1383669. PubMed ID: 38832317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis.
    Borovac JA; Novak K; Bozic J; Glavas D
    Heart Vessels; 2019 Feb; 34(2):268-278. PubMed ID: 30159656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: A meta-analysis of randomized controlled trials.
    Fan G; Guo DL
    Eur J Intern Med; 2023 Aug; 114():49-57. PubMed ID: 37062643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of the PROFUND Index on One Year Mortality in Acute Heart Failure: Results from the RICA Registry.
    Méndez-Bailon M; Iguarán-Bermudez R; Formiga-Pérez F; Arévalo Lorido JC; Suárez-Pedreira I; Morales-Rull JL; Serrado-Iglesias A; Llacer-Iborra P; Ormaechea-Gorricho G; Carrasco-Sánchez FJ; Casado-Cerrada J; Andrès E; Diez-Manglano J; Lorenzo-Villalba N; Montero-Pérez-Barquero M
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary Use of Sodium Glucose Co-Transporter 2 Inhibitors in Hospitalized Heart Failure Patients: A "Real-World" Experience.
    Xanthopoulos A; Katsiadas N; Giamouzis G; Vangelakou K; Balaskas D; Papamichalis M; Bourazana A; Chrysakis N; Kiokas S; Kourek C; Briasoulis A; Skopeliti N; Makaritsis KP; Parissis J; Stefanidis I; Magouliotis D; Athanasiou T; Triposkiadis F; Skoularigis J
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930091
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between anemia and outcome in patients hospitalized for acute heart failure syndromes: findings from Beijing Acute Heart Failure Registry (Beijing AHF Registry).
    Ye SD; Wang SJ; Wang GG; Li L; Huang ZW; Qin J; Li CS; Yu XZ; Shen H; Yang LP; Fu Y; Zheng YA; Zhao B; Yu DM; Qin FJ; Zhou DG; Li Y; Liu FJ
    Intern Emerg Med; 2021 Jan; 16(1):183-192. PubMed ID: 32356137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy.
    Lee WC; Chang WT; Hong CS; Liao CT; Huang PS; Huang SC; Lin CH; Chiang CY; Chen ZC; Shih JY
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):81. PubMed ID: 37114551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of sodium-glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta-analysis.
    Soleimani H; Saeedian B; Pasebani Y; Babajani N; Pashapour Yeganeh A; Bahirai P; Navid H; Amin A; Samsky MD; Nanna MG; Hosseini K
    ESC Heart Fail; 2024 Apr; 11(2):637-648. PubMed ID: 38124239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.
    López-Vilella R; Marqués-Sulé E; Laymito Quispe RDP; Sánchez-Lázaro I; Donoso Trenado V; Martínez Dolz L; Almenar Bonet L
    Front Cardiovasc Med; 2021; 8():618398. PubMed ID: 33748194
    [No Abstract]   [Full Text] [Related]  

  • 18. MRI Investigation of the Differential Impact of Left Ventricular Ejection Fraction After Myocardial Infarction in Elderly vs. Nonelderly Patients to Predict Readmission for Heart Failure.
    Marcos-Garcés V; Merenciano-González H; Gavara J; Gabaldón-Pérez A; López-Lereu MP; Monmeneu JV; Nuñez J; Pérez N; Ríos-Navarro C; de Dios E; Chorro FJ; Valente F; Lorenzatti D; Domenech-Ximenos B; Alonso Tello A; Maymí-Ballesteros M; Rello-Sabaté P; Morr CI; Ortiz-Pérez JT; Rodríguez-Palomares JF; Bodí V
    J Magn Reson Imaging; 2023 Nov; 58(5):1507-1518. PubMed ID: 36748793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Malnutrition, Frailty, Sarcopenia, or Cachexia.
    Horiuchi Y; Asami M; Yahagi K; Oshima A; Gonda Y; Yoshiura D; Komiyama K; Yuzawa H; Tanaka J; Aoki J; Tanabe K
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis.
    Liu T; Fan Z; Xiao B; He C; Wang S
    Cardiovasc Diabetol; 2024 Mar; 23(1):106. PubMed ID: 38528542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.